Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hunteria umbellata extract is a botanical preparation derived from the seeds or fruits of the West African tree Hunteria umbellata (family Apocynaceae). Traditionally used in African medicine for conditions such as diabetes, obesity, pain, ulcers, and infections, its aqueous seed and fruit extracts have demonstrated antihyperglycemic (blood sugar-lowering), anti-obesity, antihyperlipidemic (lipid-lowering), antioxidant, and antiplasmodial activities in preclinical studies. The hypoglycemic effect is thought to be mediated by inhibition of intestinal glucose uptake and modulation of adrenergic homeostatic mechanisms. Phytochemical analyses reveal the presence of alkaloids, flavonoids, tannins, glycosides and other bioactive compounds. Toxicity studies indicate a relatively high LD50 (>1000 mg/kg) but suggest caution due to potential mild toxicity at higher doses. No pharmaceutical company has developed this as an approved drug; it remains primarily a traditional remedy or nutraceutical candidate under investigation for metabolic syndrome-related disorders such as type 2 diabetes[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hunteria umbellata extract.